Atrys Health Sa Stock Net Income
A2T Stock | EUR 3.00 0.01 0.33% |
ATRYS HEALTH SA fundamentals help investors to digest information that contributes to ATRYS HEALTH's financial success or failures. It also enables traders to predict the movement of ATRYS Stock. The fundamental analysis module provides a way to measure ATRYS HEALTH's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ATRYS HEALTH stock.
ATRYS |
ATRYS HEALTH SA Company Net Income Analysis
ATRYS HEALTH's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current ATRYS HEALTH Net Income | (2.02 M) |
Most of ATRYS HEALTH's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ATRYS HEALTH SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition |
Based on the recorded statements, ATRYS HEALTH SA reported net income of (2.02 Million). This is 100.59% lower than that of the Healthcare sector and 102.88% lower than that of the Biotechnology industry. The net income for all Germany stocks is 100.35% higher than that of the company.
ATRYS Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ATRYS HEALTH's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ATRYS HEALTH could also be used in its relative valuation, which is a method of valuing ATRYS HEALTH by comparing valuation metrics of similar companies.ATRYS HEALTH is currently under evaluation in net income category among its peers.
ATRYS Fundamentals
EBITDA | 6.68 M | |||
Net Income | (2.02 M) | |||
Cash And Equivalents | 17.6 M | |||
Cash Per Share | 0.51 X | |||
Total Debt | 71.4 M | |||
Debt To Equity | 0.95 % | |||
Current Ratio | 1.74 X | |||
Book Value Per Share | 1.53 X | |||
Cash Flow From Operations | (1.4 M) | |||
Earnings Per Share | (0.05) X | |||
Number Of Employees | 2.4 K | |||
Beta | 0.15 | |||
Market Capitalization | 330.53 M | |||
Z Score | 2.4 |
About ATRYS HEALTH Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ATRYS HEALTH SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ATRYS HEALTH using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ATRYS HEALTH SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in ATRYS Stock
ATRYS HEALTH financial ratios help investors to determine whether ATRYS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ATRYS with respect to the benefits of owning ATRYS HEALTH security.